Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

被引：2
|
作者：
Cervera, J. [1 ]
Sole, F.
Haase, D.
Luno, E.
Such, E.
Nomdedeu, B.
Costa, D.
Bernal, T.
Vallespi, T.
Bueno, J.
Pedro, C.
Mallo, M.
Ardanaz, M. T.
Calasanz, M. J.
del Canizo, C.
Hernandez-Rivas, J. M.
Schanz, J.
Steidl, C.
Hildebrandt, B.
Carbonell, F.
Orero, M.
Ramos, F.
Marco, V.
Tormo, M.
Gomez, V.
Andreu, R.
Xicoy, B.
Amigo, M. L.
Munoz, J. A.
Bonanad, S.
Arrizabalaga, B.
Senent, M. L.
Germing, U.
Sanz, G. F.
机构：
[1] Univ Gottingen, D-3400 Gottingen, Germany
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70110-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [41] Cytogenetic study of 93 myelodysplastic syndromes
    Sole, F
    Woessner, S
    Florensa, L
    Perez-Losada, A
    Acin, P
    Besses, C
    Garcia-Eroles, L
    Sans-Sabrafen, J
    MEDICINA CLINICA, 1998, 110 (03): : 94 - 98
  • [42] Thrombocytopenia Predicts for Poor Survival In Patients with Lower Risk Myelodysplastic Syndromes (MDS)
    Cruz, Raymond
    Galili, Naomi
    Khan, Ghulam Sajjad
    Raza, Azra
    BLOOD, 2010, 116 (21) : 1638 - 1638
  • [43] Assessment of apoptosis in relation to single cytogenetic abnormalities in myelodysplastic syndromes (MDS).
    Mundle, S
    Hsu, WT
    Dutt, D
    Dar, S
    Saberwal, G
    Townsend, W
    Broderick, E
    Kaspar, C
    Alvi, S
    Shetty, V
    Allampallam, K
    Reddy, P
    Venugopal, P
    Gezer, S
    Lisak, L
    Raza, A
    BLOOD, 2001, 98 (11) : 191B - 191B
  • [44] Prognostic relevance of cytogenetic evolution and the influence of the clonal composition in patients with myelodysplastic syndromes
    Cevik, N.
    Haase, D.
    Schanz, J.
    ONKOLOGIE, 2013, 36 : 126 - 126
  • [45] EXTENDED CYTOGENETIC FOLLOW-UP AND CLINICAL-PROGRESS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    WHITE, AD
    HOY, TG
    JACOBS, A
    LEUKEMIA & LYMPHOMA, 1994, 12 (5-6) : 401 - 412
  • [46] CORRELATIONS BETWEEN CYTOLOGICAL, CLINICAL AND CYTOGENETIC FINDINGS IN MYELODYSPLASTIC SYNDROMES (MDS)
    VILA, L
    TREILLERITOUET, D
    CHARRIN, C
    FRAISSE, J
    ARCHIMBAUD, E
    FIERE, D
    BLUT, 1988, 56 (06): : C10 - C10
  • [47] CYTOGENETIC CATEGORIES OF MYELODYSPLASTIC SYNDROMES (MDS) ACCORDING TO REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM (R-IPSS)
    Gritsaev, S.
    Martinkevitch, I.
    Petrova, E.
    Kostroma, I.
    Ivanova, M.
    Martinenko, L.
    Sergeev, A.
    Abdukkadirov, K.
    HAEMATOLOGICA, 2012, 97 : 578 - 578
  • [48] Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study
    Buckstein, Rena
    Wells, Richard A.
    Zhu, Nancy
    Leitch, Heather A.
    Nevill, Thomas J.
    Yee, Karen W. L.
    Leber, Brian
    Sabloff, Mitchell
    St Hilaire, Eve
    Kumar, Rajat
    Geddes, Michelle
    Shamy, April
    Storring, John
    Kew, Andrea
    Elemary, Mohamed
    Levitt, Max
    Lenis, Martha
    Mamedov, Alex
    Zhang, Liying
    Rockwood, Ken
    Alibhai, Shabbir M. H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (01) : 88 - 101
  • [49] A REGRESSION EQUATION FOR PREDICTING SURVIVAL IN MYELODYSPLASTIC SYNDROMES (MDS) - RESULTS OF A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN 370 PATIENTS
    SANZ, GF
    VALLESPI, T
    CANIZO, MC
    SANZ, MA
    TORRABADELLA, M
    SANMIGUEL, J
    GARCIA, S
    IRRIGUIBLE, D
    BLUT, 1988, 56 (06): : C14 - C14
  • [50] The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Mukherjee, Sudipto
    Tiu, Ramon V.
    Saunthararajah, Yogen
    Keng, Michael K.
    Seastone, David J.
    Hobson, Sean
    Advani, Anjali S.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2013, 122 (21)
12345